|
MAPK8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13400400181263E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.85558251991824E-12 |
| Normal-vs-Stage2 |
9.86480000020329E-07 |
| Normal-vs-Stage3 |
2.11630000002128E-06 |
| Normal-vs-Stage4 |
1.76689999999979E-05 |
| Stage1-vs-Stage2 |
6.298800E-01 |
| Stage1-vs-Stage3 |
6.462400E-01 |
| Stage1-vs-Stage4 |
9.712600E-01 |
| Stage2-vs-Stage3 |
9.428800E-01 |
| Stage2-vs-Stage4 |
6.777600E-01 |
| Stage3-vs-Stage4 |
7.419000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.03574959509479E-12 |
| Normal-vs-AfricanAmerican |
2.79500000921473E-09 |
| Normal-vs-Asian |
2.396000E-03 |
| Caucasian-vs-AfricanAmerican |
5.457200E-01 |
| Caucasian-vs-Asian |
7.509200E-01 |
| AfricanAmerican-vs-Asian |
9.095400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64190883111814E-12 |
| Normal-vs-Female |
1.431280E-04 |
| Male-vs-Female |
1.569220E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.30389998587566E-09 |
| Normal-vs-Extreme_Weight |
6.27276008913213E-14 |
| Normal-vs-Obese |
7.49290000046088E-08 |
| Normal-vs-Extreme_Obese |
4.2056000000068E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.263600E-01 |
| Normal_Weight-vs-Obese |
2.300200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.539200E-01 |
| Extreme_Weight-vs-Obese |
1.587580E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.900400E-01 |
| Obese-vs-Extreme_Obese |
4.978000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.220300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.30990013175381E-10 |
| Normal-vs-Age(61-80Yrs) |
2.78965739397563E-12 |
| Normal-vs-Age(81-100Yrs) |
9.57160000147894E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.622200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.451640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.123620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.567640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.193200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.062600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01618713443941E-12 |
| Normal-VS-Type2 PRCC |
1.03940001050518E-09 |
| Normal-VS-KIRP CIMP |
1.132430E-01 |
| Normal-VS-Unclassified PRCC |
2.11019999999396E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.264200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.195880E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.140800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.754100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.814800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.464600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06540332112104E-11 |
| Normal-vs-N1 |
1.74363999999594E-05 |
| Normal-vs-N2 |
1.399950E-03 |
| N0-vs-N1 |
8.556000E-02 |
| N0-vs-N2 |
8.675800E-01 |
| N1-vs-N2 |
5.574400E-01 |
|
|
